HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manabu Fujimoto Selected Research

Systemic Lupus Erythematosus (Libman-Sacks Disease)

1/2021Generalized pustular psoriasis associated with systemic lupus erythematosus successfully treated with secukinumab.
5/2011Use of serum clara cell 16-kDa (CC16) levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis.
5/2010Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.
6/2009Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
2/2009Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
12/2008Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
5/2008Elevation of serum lymphotactin levels in patients with systemic sclerosis.
3/2008Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
3/2008Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
1/2008Increased serum interleukin 23 in patients with systemic sclerosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manabu Fujimoto Research Topics

Disease

59Systemic Scleroderma (Systemic Sclerosis)
11/2022 - 06/2002
44Dermatomyositis (Dermatopolymyositis)
07/2023 - 04/2003
39Neoplasms (Cancer)
11/2023 - 04/2011
31Melanoma (Melanoma, Malignant)
11/2023 - 11/2011
29Fibrosis (Cirrhosis)
01/2020 - 06/2002
27Myositis (Idiopathic Inflammatory Myopathies)
05/2024 - 02/2012
18Inflammation (Inflammations)
04/2024 - 09/2004
13Interstitial Lung Diseases (Interstitial Lung Disease)
04/2018 - 01/2010
12Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2011 - 09/2006
11Autoimmune Diseases (Autoimmune Disease)
01/2022 - 03/2007
11Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 04/2003
10Psoriasis (Pustulosis Palmaris et Plantaris)
12/2022 - 01/2008
9Dermatitis
01/2024 - 09/2004
9Sclerosis
05/2019 - 06/2002
8Neoplasm Metastasis (Metastasis)
11/2023 - 11/2011
7Contact Dermatitis (Eczema, Contact)
12/2023 - 05/2007
7Vitiligo
05/2023 - 02/2017
7Rheumatoid Arthritis
01/2023 - 11/2010
6Hemorrhage
01/2021 - 05/2007
6Disease Progression
05/2019 - 10/2008
5Atopic Dermatitis (Atopic Eczema)
03/2024 - 05/2007
5Bullous Pemphigoid (Pemphigoid)
10/2023 - 05/2007
5Necrosis
01/2022 - 04/2006
5Polymyositis
12/2021 - 01/2010
5Wounds and Injuries (Trauma)
11/2015 - 09/2007
4Extramammary Paget Disease (Paget Disease, Extramammary)
04/2024 - 11/2015
4Hypersensitivity (Allergy)
01/2023 - 05/2007
4Localized Scleroderma (Morphea)
11/2022 - 01/2003
4Amyopathic dermatomyositis
12/2021 - 04/2013
4Arthritis (Polyarthritis)
01/2019 - 01/2009
4Bronchiolitis Obliterans Syndrome
04/2017 - 12/2012
4Connective Tissue Diseases (Connective Tissue Disease)
01/2017 - 12/2007
4Arthus Reaction
09/2012 - 05/2007
3Infections
03/2024 - 09/2013
3Blister (Bulla)
12/2023 - 09/2020
3Inclusion Body Myositis
01/2023 - 04/2013
3Muscular Diseases (Myopathy)
01/2023 - 04/2013
3Alopecia Areata
01/2022 - 03/2007
3Calcinosis
01/2022 - 04/2013
3Erythema
10/2021 - 03/2010
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2021 - 07/2017
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021 - 05/2007
3Skin Manifestations
08/2020 - 10/2004

Drug/Important Bio-Agent (IBA)

64AutoantibodiesIBA
05/2024 - 06/2002
34AntibodiesIBA
10/2023 - 12/2005
24CytokinesIBA
03/2024 - 01/2003
17Proteins (Proteins, Gene)FDA Link
07/2023 - 06/2005
15Immunoglobulin G (IgG)IBA
10/2023 - 04/2003
15EnzymesIBA
08/2023 - 04/2003
15Interleukin-6 (Interleukin 6)IBA
01/2021 - 06/2002
11AntigensIBA
01/2024 - 10/2004
10Mi-2 antibodiesIBA
08/2023 - 12/2005
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2017 - 01/2003
9transcriptional intermediary factor 1IBA
08/2023 - 09/2012
9NivolumabIBA
06/2020 - 06/2016
9Bleomycin (Blenoxane)FDA LinkGeneric
01/2020 - 09/2006
9Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
07/2014 - 04/2006
8ImmunosorbentsIBA
08/2023 - 04/2003
7Interleukin-10 (Interleukin 10)IBA
11/2023 - 08/2008
7Immune Checkpoint InhibitorsIBA
07/2023 - 09/2016
7InterferonsIBA
01/2023 - 02/2011
7CollagenIBA
01/2023 - 04/2003
7Monoclonal AntibodiesIBA
05/2019 - 09/2006
7L-SelectinIBA
07/2014 - 04/2006
7ChemokinesIBA
11/2013 - 05/2008
7P-SelectinIBA
11/2011 - 09/2006
6Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
08/2023 - 05/2007
6Interleukin-17 (Interleukin 17)IBA
01/2022 - 06/2008
6AutoantigensIBA
01/2021 - 06/2002
6LigandsIBA
06/2017 - 03/2008
6E-SelectinIBA
11/2011 - 09/2006
5Immunoglobulin E (IgE)IBA
01/2024 - 02/2008
5nuclear matrix protein 2IBA
07/2023 - 11/2016
5UbiquitinIBA
07/2023 - 01/2013
5SteroidsIBA
05/2023 - 09/2016
5Imiquimod (Aldara)FDA LinkGeneric
12/2022 - 01/2020
5Indicators and Reagents (Reagents)IBA
12/2021 - 06/2009
5Biomarkers (Surrogate Marker)IBA
05/2021 - 05/2011
5Antigen-Antibody Complex (Immune Complex)IBA
07/2019 - 05/2007
5Immunoglobulins (Immunoglobulin)IBA
01/2019 - 05/2009
5anti-scl-70 autoantibodiesIBA
01/2017 - 01/2010
4artenimol (dihydroartemisinin)IBA
11/2023 - 09/2020
4HLA-DR Antigens (HLA-DR)IBA
01/2023 - 01/2022
4Messenger RNA (mRNA)IBA
07/2014 - 09/2004
4SelectinsIBA
11/2011 - 09/2006
3Toll-Like Receptors (Toll-Like Receptor)IBA
04/2024 - 06/2008
3Sirolimus (Rapamycin)FDA Link
12/2023 - 08/2010
3IntegrinsIBA
10/2023 - 01/2013
3Immunoglobulin M (IgM)IBA
07/2023 - 12/2007
3Peptides (Polypeptides)IBA
01/2023 - 04/2013
3eribulinFDA Link
01/2023 - 01/2018
3Ligases (Synthetase)IBA
10/2021 - 04/2013
3Prednisolone (Predate)FDA LinkGeneric
06/2021 - 01/2010
3Interferon Type IIBA
01/2021 - 06/2009

Therapy/Procedure

20Therapeutics
03/2024 - 10/2004
7Immunotherapy
09/2023 - 02/2017
6Drug Therapy (Chemotherapy)
04/2024 - 01/2012
5Radiotherapy
08/2021 - 01/2012
3Transplantation
06/2021 - 09/2020
3Hematopoietic Stem Cell Transplantation
01/2021 - 01/2008